LUXHT
Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingCustom
- # of holdings44
What's inside?
Holdings
All holdings as of May 17, 2024
| Oscar Health, Inc. (OSCR) | 15.87% | $4.54B | 45.77% | N/A | 0.71 |
| Natera, Inc. (NTRA) | 6.01% | $13.07B | 52.11% | 56.72% | 8.78 |
| GoodRx Holdings, Inc. (GDRX) | 3.87% | $705.63M | 7.55% | 85.64% | 3.86 |
| Hims & Hers Health, Inc. (HIMS) | 3.66% | $3.01B | 45.81% | 68.43% | 3.50 |
| Align Technology, Inc. (ALGN) | 3.37% | $20.44B | 5.76% | 70.51% | 6.11 |
| Lifestance Health Group, Inc. (LFST) | 3.32% | $2.83B | 18.94% | 24.02% | 2.52 |
| Myriad Genetics, Inc. (MYGN) | 2.69% | $2.29B | 11.59% | 62.71% | 2.53 |
| Intuitive Surgical, Inc. (ISRG) | 2.63% | $141.46B | 11.46% | 65.87% | 19.01 |
| NeoGenomics, Inc. (NEO) | 2.59% | $1.89B | 13.86% | 39.69% | 3.61 |
| EXACT Sciences Corp. (EXAS) | 2.54% | $9.30B | 5.82% | 69.66% | 5.73 |
| Veeva Systems, Inc. (VEEV) | 2.50% | $33.98B | 9.68% | 70.73% | 12.67 |
| Axonics, Inc. (AXNX) | 2.49% | $3.45B | 29.38% | 73.30% | 8.30 |
| DexCom, Inc. (DXCM) | 2.31% | $52.24B | 24.21% | 61.01% | 15.12 |
| Hologic, Inc. (HOLX) | 2.29% | $17.51B | -0.85% | 55.27% | 4.77 |
| Accolade, Inc. (ACCD) | 2.28% | $586.11M | 14.09% | 34.67% | 1.86 |
| IQVIA Holdings, Inc. (IQV) | 2.22% | $42.12B | 2.89% | 27.59% | 3.90 |
| Schrödinger, Inc. (SDGR) | 2.18% | $1.45B | -43.51% | 51.61% | 8.71 |
| iRhythm Technologies, Inc. (IRTC) | 2.04% | $2.95B | 18.39% | 66.34% | 7.34 |
| Guardant Health, Inc. (GH) | 2.02% | $3.10B | 30.90% | 61.25% | 4.52 |
| Clover Health Investments Corp. (CLOV) | 1.97% | $362.04M | -34.36% | N/A | 0.21 |
| Tandem Diabetes Care, Inc. (TNDM) | 1.82% | $3.06B | 13.16% | 49.39% | 3.02 |
| Inspire Medical Systems, Inc. (INSP) | 1.79% | $4.61B | 28.24% | 84.91% | 8.99 |
| Veracyte, Inc. (VCYT) | 1.79% | $1.75B | 17.50% | 62.50% | 3.89 |
| Fulgent Genetics, Inc. (FLGT) | 1.77% | $661.63M | -2.54% | 31.19% | 1.22 |
| Health Catalyst, Inc. (HCAT) | 1.75% | $410.29M | 1.16% | 34.92% | 1.22 |
| PROCEPT BioRobotics Corp. (PRCT) | 1.75% | $3.50B | 82.51% | 53.55% | 15.20 |
| Progyny, Inc. (PGNY) | 1.73% | $2.67B | 7.62% | 22.44% | 3.16 |
| CareDx, Inc. (CDNA) | 1.70% | $807.30M | -6.75% | 63.13% | 1.32 |
| Twist Bioscience Corp. (TWST) | 1.48% | $2.74B | 25.13% | 41.01% | 6.41 |
| ResMed, Inc. (RMD) | 1.40% | $32.11B | 7.17% | 56.94% | 6.57 |
| Globus Medical, Inc. (GMED) | 1.38% | $7.25B | 119.26% | 55.30% | 3.87 |
| Teladoc Health, Inc. (TDOC) | 1.35% | $2.16B | 2.68% | 54.74% | 1.15 |
| Definitive Healthcare Corp. (DH) | 1.32% | $648.64M | 7.23% | 64.68% | 4.89 |
| Castle Biosciences, Inc. (CSTL) | 1.31% | $669.20M | 73.59% | 77.28% | 1.57 |
| Masimo Corp. (MASI) | 1.17% | $6.59B | -12.78% | 49.05% | 4.43 |
| Doximity, Inc. (DOCS) | 1.13% | $3.42B | 13.45% | 89.34% | 10.07 |
| 10X Genomics, Inc. (TXG) | 1.01% | $2.64B | 5.01% | 67.78% | 6.72 |
| Olink Holding AB (OLK) | 1.00% | $2.98B | 3.95% | 60.68% | 16.58 |
| Insulet Corp. (PODD) | 0.97% | $13.12B | 23.35% | 70.16% | 7.46 |
| Illumina, Inc. (ILMN) | 0.93% | $17.69B | -1.01% | 61.99% | 5.12 |
| Adaptive Biotechnologies Corp. (ADPT) | 0.83% | $532.00M | 11.23% | 50.35% | 2.22 |
| Cytek Biosciences, Inc. (CTKB) | 0.72% | $800.76M | 20.96% | 51.30% | 3.11 |
| Nevro Corp. (NVRO) | 0.57% | $418.71M | 5.78% | 66.30% | 1.09 |
| Pacific Biosciences of California, Inc. (PACB) | 0.48% | $550.16M | -0.23% | 11.41% | 6.89 |
